SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Astellas Pharma US Release: FDA Accepts Supplemental New Drug Application for Tarceva® (erlotinib) Tablets for Genetically Distinct Form of Advanced Lung Cancer